Sign in
4

Changes in Ownership

Twist Bioscience Corp Filed Acc 0001214659-26-002041

President and COO sold 5,250 shares at an average $50.16 ($263,359)

  • President and COO acquired 3,712 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Finn Patrick John · President and COO

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2026-02-12 Exercise or conversion : show line 1 in the form 10b5-1 +1,000 $23.33 $23,330 308,788 D
2026-02-12 Exercise or conversion : show line 2 in the form 10b5-1 +1,500 $26.66 $39,990 310,288 D
2026-02-12 Sale : show line 3 in the form 10b5-1 −3,500 $50.23 $175,788 306,788 D
2026-02-13 Exercise or conversion : show line 4 in the form 10b5-1 +500 $23.33 $11,665 307,288 D
2026-02-13 Exercise or conversion : show line 5 in the form 10b5-1 +712 $26.66 $18,982 308,000 D
2026-02-13 Sale : show line 6 in the form 10b5-1 −1,750 $50.04 $87,572 306,250 D
Open-market sales · 5,250 sh · avg $50.16 · $263,359

Table II: Derivative

4 lines
Date Transaction Shares Owned after D/I
2026-02-12 Exercise or conversion : show line 7 in the form 10b5-1 Stock Option (right to buy) −1,500 33,012 D
2026-02-12 Exercise or conversion : show line 8 in the form 10b5-1 Stock Option (right to buy) −1,000 18,705 D
2026-02-13 Exercise or conversion : show line 9 in the form 10b5-1 Stock Option (right to buy) −712 32,300 D
2026-02-13 Exercise or conversion : show line 10 in the form 10b5-1 Stock Option (right to buy) −500 18,052 D
Loading xslF345X05/marketforms-72141.xml…